Dr. Mark Douglas Frey, MD

Dr. Frey practices at Canton-Potsdam Hospital in Potsdam, New York, part of Rochester Regional Health.

Dr. Frey's NPI, 1336116797, was assigned on March 3, 2006. Dr. Frey graduated from UNMC in 1982. Dr. Frey holds New York license 330710.

Dr. Frey's primary practice is Canton-Potsdam Hospital, at 50 Leroy Street, Potsdam, NY 13676 in St. Lawrence County. The practice phone is (315) 265-3300.

Dr. Frey's primary practice is Canton-Potsdam Hospital in Potsdam, New York, part of Rochester Regional Health. Dr. Frey is also affiliated with Massena Hospital. The medical group on file is Canton-Potsdam Hospital. Dmand AI also links Dr. Frey to 3 more medical groups and 1 group practice or clinic, each named with a free account. Dr. Frey's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Frey practices, 3 sites in all. Vendor and product names are available with a free account.

Otolaryngology is Dr. Frey's primary specialty in the NPI Registry, under taxonomy code 207Y00000X. Dr. Frey is board certified in otolaryngology by the American Board of Otolaryngology - Head and Neck Surgery. Dmand AI has Dr. Frey's licenses on file in 4 states: New York, Nebraska, Iowa and Florida.

Dmand AI lists acute sinusitis, chronic nasal allergies, chronic sinusitis, ear eustachian tube disorders, ear infection, endoscopic sinus surgery, hearing loss and impairment and larynx and vocal cord disease among the conditions Dr. Frey treats.

CMS data shows 1,294 Medicare services from Dr. Frey across 6 procedure codes in 2024, for 437 Medicare patients. Medicare paid $32,306 for them. Every service was in an office.

CMS counts 437 Medicare patients who saw Dr. Frey in 2024. The largest group is 75 to 84, with 176 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 9% are also on Medicaid. Their average risk score is 1.24, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Frey's median patient age at 67, with 54% women.

In 2024, Dr. Frey wrote 295 Medicare Part D claims for 142 patients. 91% of them were for generic drugs. CMS names the drug for 214 of them, across 10 drugs with 11 or more claims each, at $4,709 in total drug cost. In 2023, CMS named 187 claims across 8 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 99 out of 100 for Dr. Frey for performance year 2024, reported through an alternative payment model (APM). Dr. Frey accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

CMS Open Payments shows 73 general payments to Dr. Frey from 14 drug and device companies from 2016 to 2024. Food and beverage make up the largest share, 76% of the total. Intersect ENT, Inc. paid the most, $2,627.

Dmand AI lists 3 awards for Dr. Frey, most recently CMS Stage 1 EHR in 2013.

Dr. Frey graduated from UNMC in 1982. Dr. Frey is a member of NHS and ACS.

Dr. Frey is in network with 17 carriers, including Aetna, Elevance and MVP Health Care. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.